TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/09/2023
Voltar para busca
Dado oficial do USPTO
EFFPHA, EFFICIENT PHARMA MANAGEMENT CORP.
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
29
Atualização mais recente
05/09/2023
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
42
Data de depósito
06/05/2010
Data de registro
28/12/2010
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/06/2020
Última transação
05/09/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Primeiro uso
15/10/2009
Primeiro uso no comércio
15/10/2009
Código do desenho
3
Tipo de titular
03
Localização do titular
Taipei, TW
Examinador
HOFFMAN, DAVID AARON
Unidade examinadora
L70
Localização atual
GENERIC WEB UPDATE
Descrição da marca
The mark consists of square design to the left of the wording "EffPha" in blue. The color blue also appears in the upper right corner portion of a square design and has a vertical gradient going from a darker blue to a milder blue, then to a light blue. The color orange appears in the leftmost vertical stripe of the square design. The color green appears in the lower right portion of the square design. A circular figure is cut out of the center of the square design, which is transparent in color. Two vertical parallel lines cut through the square design, also transparent in color. The wording "Efficient Pharma Management Corp." appears below the square design and the wording "EffPha", in gray. The color white merely indicates background and is not part of the mark.
Titulares e representantes
Titulares
E. C. (pessoa física)
Representantes
Alan D. Kamrath Best & Flanagan LLP
Classificação técnica
Classes Nice
Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Bacteriological consultation and research; Biochemical research and development; Biological research; Chemical analysis; Chemical research; Chemicalbiochemicalbiological and bacteriological research and analysis; Chemist services; Chemistry consultation; Compiling data for research purposes in the field of medical science and medical consultancy; Conducting early evaluations in the field of new pharmaceuticals; Consultancy pertaining to pharmacology; Consulting services in the fields of biotechnologypharmaceutical research and development and genetic science; Consulting services in the fields of biotechnologypharmaceutical research and developmentlaboratory testingdiagnosticspharmacogenetics; Cosmetic research consultation; Cosmetics research; Cosmetics research for others; Development of pharmaceutical preparations and medicines; Drug discovery services; Information on the subject of scientific research in the field of biochemistry and biotechnology; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical research and development; Pharmaceutical research services; Product development; Product development consultation; Product development for others; Product research; Product research and development; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development for new products for others; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Research in the field of chemistry; Research on the subject of pharmaceuticals; Scientific research and development
Publicações
Histórico de despachos e eventos da marca no USPTO.
29 publicações encontradas
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/09/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/09/2023
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/06/2020
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/06/2020
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/06/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/06/2020
E89R
TEAS SECTION 8 & 9 RECEIVED
25/03/2020
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
28/12/2019
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
15/06/2016
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
15/06/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
15/06/2016
E815
TEAS SECTION 8 & 15 RECEIVED
08/04/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/04/2016
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
28/12/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
28/12/2010
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/10/2010
PUBO
PUBLISHED FOR OPPOSITION
12/10/2010
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/09/2010
ALIE
ASSIGNED TO LIE
07/09/2010
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
24/08/2010
XAEC
EXAMINER'S AMENDMENT ENTERED
24/08/2010
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
24/08/2010
GNEA
EXAMINERS AMENDMENT E-MAILED
24/08/2010
CNEA
EXAMINERS AMENDMENT -WRITTEN
24/08/2010
DOCK
ASSIGNED TO EXAMINER
18/08/2010
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
12/05/2010
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/05/2010
NWAP
NEW APPLICATION ENTERED
10/05/2010
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace EFFPHA, EFFICIENT PHARMA MANAGEMENT CORP. ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.